Find a Researcher
TCRN: a translational cancer research program funded by the Cancer Institute NSW.
Targeting the Wnt signalling pathway - a new anti-metastatic and epigenetic therapy for ovarian cancer
Ovarian cancer is a difficult disease to treat, because often women are diagnosed at an advanced stage of the disease. We will investigate a number of genes involved in ovarian cancer in order to identify one that could act as a signal for early detect...